15+ hour, 46+ min ago  (116+ words) US late-stage biotech Immunic (Nasdaq: IMUX) today announced that it has appointed Dr Michael Panzara as chief medical officer (CMO), effective April 24, 2026. This article is accessible to registered users, to continue reading please register for free." A free trial will…...

10+ hour, 6+ min ago  (119+ words) CRISPR gene editing specialist Intellia Therapeutics (Nasdaq: NTLA) has announced positive topline results from the global Phase III HAELO clinical trial of lonvo-z in hereditary angioedema (HAE). This article is accessible to registered users, to continue reading please register for…...

1+ day, 18+ hour ago  (137+ words) India's Sun Pharmaceutical Industries (BSE: 524715) and Organon & Co (NYSE: OGN) today announced a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for $14. 00 per share in an all'cash transaction with an enterprise valuation of $ 1. 75 billion. This…...

2+ day, 19+ hour ago  (91+ words) This article is accessible to registered users, to continue reading please register for free." A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a…...

4+ day, 14+ hour ago  (111+ words) The European Medicines Agency (EMA) human medicines committee (CHMP) recommended five new medicines for approval at its April 2026 meeting. This article is accessible to registered users, to continue reading please register for free." A free trial will give you access…...

4+ day, 19+ hour ago  (130+ words) US biotech Tivic Health Systems (Nasdaq: TIVC) will rename itself Valion Bio and adopt the ticker VBIO from April 28, formalizing a shift away from consumer medical devices toward a biologics-led strategy anchored by its lead candidate entolimod. This article is…...

4+ day, 18+ hour ago  (120+ words) Privately-held Canadian generic drugmaker Apotex and US specialty drug company Cumberland Pharmaceuticals (Nasdaq: CPIX) have entered into a strategic transaction to integrate Cumberland's US branded businesses into Apotex. This article is accessible to registered users, to continue reading please register…...

1+ week, 14+ hour ago  (141+ words) US biotech Moderna (Nasdaq: MRNA) today announced that the European Commission (EC) has granted marketing authorization for m COMBRIAX (m RNA-1083), the company's m RNA combination vaccine for active immunization for the prevention of influenza disease and COVID-19 caused by…...

1+ week, 16+ hour ago  (121+ words) Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced the launch of Serif Biomedicines, a biotechnology company pioneering modified DNA as a new class of medicines. This article is accessible to registered users, to continue reading…...

1+ week, 16+ hour ago  (138+ words) US biotech Arcus Biosciences (NYSE: RCUS) has halted its Phase III STAR-121 study of domvanalimab in first-line non'small-cell lung cancer after an interim analysis found the trial unlikely to meet its goals, according to a filing with the US Securities…...